• A <em>GDF2</em> missense mutation potentially involved in the pathogenesis of hereditary hemorrhagic telangiectasia: a case report
• A 37-Year-Old Man with Familial Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations Presenting with Seizures and a Diagnosis of Brain Abscesses
• A GDF2 missense mutation potentially involved in the pathogenesis of hereditary hemorrhagic telangiectasia: a case report
• A novel germline SMAD4 variant detected in a Japanese family with juvenile polyposis syndrome and hereditary hemorrhagic telangiectasia
• A rare homozygous missense GDF2 (BMP9) mutation causing PAH in siblings: Does BMP10 status contribute?
• An Uncommon Cause of Hemobilia
• ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia
• Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review
• Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL)
• Application of contrast-enhanced ultrasound in hemothorax of hereditary hemorrhagic telangiectasia: A case report and literature review
• Assessing the Psychometric Validity of the Epistaxis Severity Score: Internal Consistency and Test-Retest Reliability
• Association of socioeconomic status with the management outcome of unruptured intracranial arteriovenous malformation
• Blood flow regulates acvrl1 transcription via ligand-dependent Alk1 activity
• Brain Abscess and Stroke in Children and Adults With Hereditary Hemorrhagic Telangiectasia: Analysis of a Large National Claims Database
• Brain AVM compactness score in children with hereditary hemorrhagic telangiectasia
• Can aura migraine be elicited by isolated pulmonary arteriovenous fistula?-A case report
• Chronic traumatic encephalopathy pathognomonic lesions occurring in isolation adjacent to infiltrative and non-infiltrative white matter lesions
• Comparative Treatment of Mucocutaneous Lesions in Hereditary Haemorrhagic Telangiectasia Patients With Dual Sequential Pulsed Dye Laser and Neodymium: Yttrium-Aluminium-Garnet Versus Neodymium: Yttrium-Aluminium-Garnet Laser Alone: A Double-Blind Randomiz
• Comparative Treatment of Mucocutaneous Lesions in Hereditary Haemorrhagic Telangiectasia Patients With Dual Sequential Pulsed Dye Laser and Neodymium: Yttrium-Aluminium-Garnet Versus Neodymium: Yttrium-Aluminium-Garnet Laser Alone: A Double-Blind Randomiz
• Comparative treatment of mucocutaneous lesions in hereditary hemorrhagic telangiectasia patients with dual sequential pulsed dye laser and neodymium: yttrium-aluminum-garnet versus neodymium: yttrium-aluminum-garnet laser alone: a double-blind randomized
• Comparison of Transthoracic Contrast Echocardiography with High-Resolution Chest CT after Embolization of Pulmonary Arteriovenous Malformation
• Computational and Experimental Analyses for Pathogenicity Prediction of <em>ACVRL1</em> Missense Variants in Hereditary Hemorrhagic Telangiectasia
• Computational and Experimental Analyses for Pathogenicity Prediction of ACVRL1 Missense Variants in Hereditary Hemorrhagic Telangiectasia
• Conservative management by embolization of a ruptured renal arterio-venous malformation (AVM) in Hereditary Hemorrhagic Telangiectasia (HHT)
• Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia
• Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
• Dysfunction of endothelial BMP-9 signaling in pulmonary vascular disease
• Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial
• Efficacy and Safety of Tacrolimus as Treatment for Bleeding Caused by Hereditary Hemorrhagic Telangiectasia: An Open-Label, Pilot Study
• Efficacy and Safety of Venous Sac Embolization With or Without Feeding Artery Embolization Versus Feeding Artery Embolization Alone in the Management of Pulmonary Arteriovenous Malformations: A Systematic Review and Meta-analysis
• Efficacy of Gabapentin For Post-COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial
• Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management
• Embolization of De Novo Pulmonary Arteriovenous Malformations Using High-Volume Detachable Non-Fibered Coils: Propensity-Matched Comparison to Traditional Coils
• Evaluation of Aav Capsids and Delivery Approaches for Hereditary Hemorrhagic Telangiectasia Gene Therapy
• Evaluation of AAV Capsids and Delivery Approaches for Hereditary Hemorrhagic Telangiectasia Gene Therapy
• Evolution of Pulmonary Arteriovenous Malformations: The Role of Contrast Echocardiography
• Functional filter for whole-genome sequencing data identifies HHT and stress-associated non-coding SMAD4 polyadenylation site variants &gt;5 kb from coding DNA
• Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia: Long-term results of endoscopic treatment
• Generation of a Syngeneic Heterozygous <em>ACVRL1^(wt/mut)</em> Knockout iPS Cell Line for the In Vitro Study of HHT2-Associated Angiogenesis
• Genetic analysis of a family with hereditary hemorrhagic telangiectasia caused by endoglin gene mutation
• Health-Related Quality of Life Outcome Measures in Individuals With Hereditary Hemorrhagic Telangiectasia: A Scoping Review
• Hepatic involvement in hereditary hemorrhagic telangiectasia mimicking focal nodular hyperplasia
• Hereditary haemorrhagic telangiectasia in Danish patients with pathogenic variants in SMAD4: a nationwide study
• Hereditary Hemorrhagic Telangiectasia (Osler's Disease): Systemic, Interdisciplinary, Relatively Common-and Often Missed
• Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder of women
• Hereditary hemorrhagic telangiectasia with hepatic arteriovenous shunt diagnosed due to liver damage
• Hereditary Hemorrhagic Telangiectasia With Multiple Ear, Nose, and Throat (ENT) Manifestations: A Case Report
• Hereditary Hemorrhagic Telangiectasia with Recurrent Epistaxis, Telangiectasia, Hepatic Arteriovenous Malformation, and a Poorly Developed Middle Cerebral Artery in a Patient with a Novel Mutation in the ACVRL1 Gene
• High risk of ischaemic stroke amongst patients with hereditary haemorrhagic telangiectasia
• Human <em>SMAD4</em> Genomic Variants Identified in Individuals with Heritable and Early-Onset Thoracic Aortic Disease
• Identification of Choroidal Vascular Abnormalities in Patients with Hereditary Hemorrhagic Telangiectasia (HHT)
• Identifying racial disparities in hereditary hemorrhagic telangiectasia
• Impact of SARS-CoV-2 infection in patients with hereditary hemorrhagic telangiectasia: epidemiological and clinical data from the comprehensive Italian retrospective multicenter study
• Improving Hereditary Hemorrhagic Telangiectasia Molecular Diagnosis: A Referral Center Experience
• Iron deficiency responses and integrated compensations in patients according to hereditary hemorrhagic telangiectasia ACVRL1, ENG and SMAD4 genotypes
• Liver imaging and pregnancy: what to expect when your patient is expecting
• Localized conditional induction of brain arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia
• Long-term use of somatostatin analogs for chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
• Longitudinal Assessment of Curacao Criteria in Children with Hereditary Hemorrhagic Telangiectasia
• Management outcomes of peripontine arteriovenous malformation patients presenting with trigeminal neuralgia
• Meta-analysis of efficacy and safety of bevacizumab in the treatment of hereditary hemorrhagic telangiectasia epistaxis
• Molecular mechanisms and clinical manifestations of hereditary hemorrhagic telangiectasia
• Most-Cited Patient-Reported Outcome Measures Within Otolaryngology-Revisiting the Minimal Clinically Important Difference: A Review
• Multi-organ hereditary hemorrhagic telangiectasia: A case report
• Multiple brain arteriovenous malformations: systematic review and individual patient data meta-analysis
• Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT
• Not Just Another "Bloody" Case of Right Heart Failure
• Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: A retrospective study
• Pediatric Lung Transplantations: New Possibilities and Challenges in Treatment of Children With End-Stage Respiratory Failure
• Phenotypic characterisation of <em>SMAD4</em> variant carriers
• Preliminary Experience with a Low-Profile High-Density Braid Occluder for Transcatheter Embolization of Pulmonary Arteriovenous Malformations
• Preliminary Experience With Novel Straight 3-Fr Guiding Sheath for Transradial Access in Endovascular Treatment: Feasibility and Safety
• Prevalence and Characteristics of Intracranial Aneurysms in Hereditary Hemorrhagic Telangiectasia
• Prevalence and Predictors of Hereditary Hemorrhagic Telangiectasia and Capillary-Malformation Arteriovenous Malformation Syndrome Among Children with Neurovascular Malformations
• Prevalence and risk factors for bleeding in hereditary hemorrhagic telangiectasia: a National Inpatient Sample study
• Prevalence of hereditary hemorrhagic telangiectasia in a medical care program organization in Buenos Aires, Argentina
• Pro-angiogenic changes of T-helper lymphocytes in hereditary hemorrhagic telangiectasia
• Prognostic Factors for Survival Using a Clinical Severity Staging System Among Patients With Acute Invasive Fungal Sinusitis
• Pulmonary Arteriovenous Malformations: What the Interventional Radiologist Should Know
• Pulmonary vascular phenotype identified in patients with <em>GDF2</em> (<em>BMP9</em>) or <em>BMP10</em> variants: an international multicentre study
• Recurrence of Pulmonary Arteriovenous Malformation after Embolization in Patients with Pulmonary Hypertension
• Risk factors and clinical features associated with basal ganglia manganese deposition in patients with hereditary hemorrhagic telangiectasia
• Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia
• Schizencephaly in Hereditary Hemorrhagic Telangiectasia
• Shear Stress and Sub-Femtomolar Levels of Ligand Synergize to Activate ALK1 Signaling in Endothelial Cells
• Significance of transesophageal contrast echocardiography with the agitated saline test for diagnosing pulmonary arteriovenous malformations
• SMAD4 maintains the fluid shear stress set point to protect against arterial-venous malformations
• Stereotactic radiosurgery for brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia
• Surgical treatment of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a single-center experience
• Targeted Diode Laser Therapy for Oral and Perioral Capillary-Venous Malformation in Pediatric Patients: A Prospective Study
• The ENG/VEGFalpha Pathway Is Likely Affected by a Nonsense Variant of Endoglin (ENG)/CD105, Causing Hereditary Hemorrhagic Telangiectasia Type 1 (HHT1) in a Chinese Family
• Thromboembolic hazard in hereditary hemorrhagic telangiectasia
• Thyroid Arteriovenous Malformation in Hereditary Hemorrhagic Telangiectasia: Insights on Successful Noninvasive Imaging
• TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)-A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial
• Treatments of Epistaxis in Hereditary Hemorrhagic Telangiectasia: Systematic Review and Network Meta-Analysis
• Ultra-low dose chest CT for the diagnosis of pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia
• Update on pulmonary arteriovenous malformations
• Use of Polyurethane-Covered Stents for Exclusion of Pulmonary Arteriovenous Malformations
• Usefulness of endoscopic endonasal underwater surgery using a combination of coblation and a lens-cleaning system for hemostasis in hereditary hemorrhagic telangiectasia
• VEGFR2 Expression Correlates with Postnatal Development of Brain Arteriovenous Malformations in a Mouse Model of Type I Hereditary Hemorrhagic Telangiectasia